Clinical Trial Update: A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing a lopinavir/ritonavir-based therapy with an efavirenz-based standard of care in treatment-naive HIV-infected adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)
• Sustiva (efavirenz)

Snippet

Sponsor: Abbott | Conditions: HIV Infections | Phase 2 | Status: COMPLETED